Latest Fda Approved Drugs Information Systems

January 19, 2012 - Nursing home residents with dementia who are selected using serotonin inhibitors reuptake (SSRIs), a decline that SSRIs, new research shows do not use the injury as compared with risk is increased. In addition, the risk is dose dependent, average nonusers, authors, Rotterdam, Erasmus University Medical Centre, Netherlands, reported in S. Carolyn Sterke, MSc, lead 3 times the risk compared with those using food  with.   Carolyn Sterke "Even at low doses, SSRIs in nursing home residents with dementia fall hazards are associated with a growing danger," the authors write. A hypnotic or sedative SSRI use with increased risk include even more. The study, published online January 18 in the British Journal of Clinical Pharmacology are. Vulnerable population "The poor are elderly patients," Josepha A. I  Cheong, MD, University of Florida College of Medicine, Gainesville, Florida, who was not involved in the research professor of psychiatry, Medscape M

January 20, 2012 - The international team of medical experts are calling into question the safety and efficacy of anti-flu drug Tamiflu, oseltamivir article), saying that the review of unpublished data indicates non-compliance and that the drug's manufacturer, Roche, has failed to provide access  to a range of information on its content. review was published online January 18, the Cochrane Library. Governments around the world spent billions of dollars stockpiling oseltamivir and zanamivir (Relenza, GlaxoSmithKline) - neuraminidase inhibitor drugs have been recommended by the World Health Organization, 2002.  To treat flu pandemic. This class of drugs, data integrity and continues to be debate, however.  In a previous Cochrane review published in 2008., Researchers documented a significant concern for publication bias in drug.  Importantly, they reported that as much as 60% of patient data from the Phase 3 trials for oseltamivir treatment has never been published. Unpublished data

Some organizations may disagree top information permanently attention deficit hyperactivity disorder (ADHD) drug shortage in the United States of America, and how or even if it can get resolved, but many prescribers across the country, it is still very real and problematic situation. Last year in May.  Published history of the Medscape Medical News reported that was released a few articles about the lack of medicines used to treat ADHD, including certain brands of dextroamphetamine and amphetamine doses of Adderall, Shire PLC), and methylphenidate article Ritalin, Novartis), and  the generic versions. This is a situation that the U.S. Food and Drug Administration (FDA) has said, is basically out of his control.  Manufacturers say that the shortage is increased demand and quotas, which was set too low on drugs Administration (DEA) ingredients such as amphetamine salts.  DEA said it is a problem that is going somewhere in the production process, because we believe there is plenty of sup

January 19, 2012 (Houston, Texas) - A New advice suggests that sexual activity is safe for most patients with heart disease that doctors and patients and their partners should seek to debate the subject of sex [1].  The guidelines come from the first time, the American Heart Association (AHA) scientific statement on this issue, which is published online today in circulation. Lead author Dr Glenn N Levine (Baylor College of Medicine, Houston, TX) told heartwire that the guidelines are probably the most comprehensive on the subject to date and has been collected from various areas of expertise, including cardiology, exercise physiology, sexual counseling, and urology.  Doctors, patients and partners do not want to talk about sexual activity, but it is something, which is an important quality of life for many people and we do not want to see patients to abstain from sex, from concern about the need to speed up the heart attack or sudden death, "- he notes. Only those patients who sh